Page last updated: 2024-08-23

staurosporine and nvp-cgm097

staurosporine has been researched along with nvp-cgm097 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Antonakos, B; Barys, L; Cooke, VG; Cowens, K; Galinsky, I; Griffin, JD; Halilovic, E; Ito, M; Jeay, S; McDonough, SM; Nelson, E; Nonami, A; Ren, T; Sanda, T; Sattler, M; Simkin, I; Stone, R; Weisberg, E; Wiesmann, M; Wuerthner, JU; Yuan, J	1

Other Studies

1 other study(ies) available for staurosporine and nvp-cgm097

Article	Year
Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097. Molecular cancer therapeutics, 2015, Volume: 14, Issue:10 Topics: Animals; Antineoplastic Agents; Apoptosis; Benzothiazoles; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Female; Gene Expression; Humans; Inhibitory Concentration 50; Isoquinolines; Leukemia, Myeloid, Acute; Mice, Inbred NOD; Mice, SCID; Phenylurea Compounds; Piperazines; Proto-Oncogene Proteins c-mdm2; Staurosporine; Tumor Burden; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays	2015

Article

Year

Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097.

Molecular cancer therapeutics, 2015, Volume: 14, Issue:10

Topics: Animals; Antineoplastic Agents; Apoptosis; Benzothiazoles; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Female; Gene Expression; Humans; Inhibitory Concentration 50; Isoquinolines; Leukemia, Myeloid, Acute; Mice, Inbred NOD; Mice, SCID; Phenylurea Compounds; Piperazines; Proto-Oncogene Proteins c-mdm2; Staurosporine; Tumor Burden; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2015